Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New proton beam combo could shrink pancreatic tumors before surgery

NCT ID NCT04894643

First seen Apr 24, 2026 · Last updated May 21, 2026 · Updated 9 times

Summary

This study tests a new approach for people with borderline resectable pancreatic cancer—tumors that are hard to remove surgically. Participants first receive two chemotherapy drugs, then proton radiation combined with another chemo drug, followed by surgery if possible. The goal is to see if this combination is safe and helps shrink the tumor enough for successful removal.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Surgery, LK Wiener Neustadt

    RECRUITING

    Wiener Neustadt, 2700, Austria

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • EBG MedAustron GmbH

    RECRUITING

    Wiener Neustadt, Lower Austria, 2700, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.